Algert Global LLC’s Bridgebio Pharma Inc Position
Does Algert Global LLC own Bridgebio Pharma Inc (BBIO)? Yes — 283.9K shares worth $21M (+0.32% of its 13F portfolio) as of Q1 2026, down from 341.0K shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
283.9K
% of Portfolio
+0.32%
Quarters Held
15
currently held
Position History BBIO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 283.9K | $21M | +0.32% |
| Q4 2025 | 341.0K | $26M | +0.41% |
| Q3 2025 | 114.9K | $6M | +0.10% |
| Q2 2025 | 64.8K | $3M | +0.06% |
| Q4 2024 | 23.6K | $648,000 | +0.02% |
| Q3 2024 | 136.4K | $3M | +0.09% |
| Q2 2024 | 55.8K | $1M | +0.05% |
| Q1 2024 | 89.4K | $3M | +0.11% |
| Q4 2023 | 87.6K | $4M | +0.14% |
| Q3 2023 | 65.6K | $2M | +0.08% |
| Q2 2023 | 39.9K | $686,000 | +0.03% |
| Q1 2023 | 42.3K | $702,000 | +0.03% |
| Q4 2022 | 73.3K | $559,000 | +0.03% |
| Q2 2022 | 38.4K | $349,000 | +0.03% |
| Q1 2022 | 40.1K | $407,000 | +0.03% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Algert Global LLC’s full portfolio or all institutional holders of BBIO.